Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 588 | 584 | 460 | 435 | 35,404 |
| Gross Profit | 588 | 584 | 460 | 435 | 35,404 |
| Operating Expenses | 5,902 | 5,677 | 7,044 | 6,296 | 6,276 |
| Operating Income | -5,314 | -5,093 | -6,584 | -5,861 | 29,128 |
| Other Income | 14 | 17 | 28 | 28 | 13 |
| Pre-tax Income | -5,300 | -5,076 | -6,556 | -5,833 | 29,141 |
| Net Income Continuous | -5,300 | -5,076 | -6,556 | -5,833 | 29,141 |
| Net Income | $-5,300 | $-5,076 | $-6,556 | $-5,833 | $29,141 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.12 | -0.12 | 0.75 |
| EPS Basic Continuous Ops | -0.10 | -0.10 | -0.12 | -0.12 | 0.76 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.12 | -0.12 | 0.75 |
| EPS Diluted Continuous Ops | -0.10 | -0.10 | -0.12 | -0.12 | 0.76 |
| EBITDA(a) | $-5,420 | $-5,041 | $-6,480 | $-5,521 | $29,205 |